DiaMedica Therapeutics

DMAC

Valor de mercado US$ 521 mi

#	Nome	Posição	Valor negociado	Ações Variação	Variação na participação
1	MHP 1 Manatuck Hill Partners Westport, Connecticut	US$ 564 mil	+US$ 16,5 mil	+5.100	+2%
2	2 Granite Point Capital Management Boston, Massachusetts	US$ 470 mil	-US$ 8,86 mil	-2.740	-1%
3	3 Worth Venture Partners Fort Lee, New Jersey	US$ 294 mil	+US$ 30 mil	+9.287	+7%
4	4 Wexford Capital West Palm Beach, Florida	US$ 184 mil	-US$ 1,01 mi	-311.140	-78%
5	5 Vanguard Group Malvern, Pennsylvania	US$ 166 mil	+US$ 151 mil	+46.817	+137%
6	6 Millennium Management New York	US$ 145 mil	-US$ 91,9 mil	-28.421	-29%
7	7 BlackRock New York	US$ 53 mil	-US$ 4,73 mil	-1.463	-5%
8	8 Geode Capital Management Boston, Massachusetts	US$ 31 mil	+US$ 49,8 mil	+15.399	Nova
9	9 Stonepine Capital Management Bend, Oregon	US$ 28 mil	+US$ 44,3 mil	+13.705	Nova
10	10 Commonwealth Equity Services Waltham, Massachusetts	US$ 27 mil	+US$ 42,9 mil	+13.277	Nova
11	11 UBS Group Zurich, Switzerland	US$ 5 mil	+US$ 336	+104	+5%
12	12 Royal Bank of Canada Toronto, Ontario, Canada	US$ 5 mil	+US$ 860	+266	+14%
13	13 Patriot Financial Group Insurance Agency Westborough, Massachusetts	US$ 4 mil	–	–	–
14	14 Bank of Montreal Toronto, Ontario, Canada	US$ 1 mil	–	–	–
15	15 Goldman Sachs New York	–	-US$ 253 mil	-51.061	Encerrada
16	16 Eidelman Virant Capital Saint Louis, Missouri	–	-US$ 173 mil	-35.000	Encerrada
17	17 FNY Investment Advisers New York	–	-US$ 2 mil	-521	Encerrada
18	18 Bank of America Charlotte, North Carolina	–	+US$ 682	+211	Nova